NBDHEX acts as an anticancer agent by inhibiting GSTs catalytic activity, avoiding inconvenience of the inhibitor extrusion from the cell by specific pumps and disrupting the interaction between the GSTP1-1 and key signaling effectors
While not a formal contraindication, clinicians generally defer initiation of tirzepatide until patients with hyperthyroidism are euthyroid, as overlapping symptoms and cardiovascular effects could complicate assessment of medication tolerance and efficacy
Why Dose Escalation Schedules Exist in GLP-1 Therapy The standard Wegovy dose escalation starts at 0.25 mg once weekly, increases to 0.5 mg in week 5, then climbs to 1.0 mg, 1.7 mg, and finally 2.4 mg over a 1620 week timeline
PPS will be encouraged to share best practices and challenges, and receive assistance and guidance from other PPS counterparts on how to best implement and meet the objectives of their DSRIP Project Plans
Toxic solvent residues DMF (dimethylformamide) Known liver toxin Associated with reproductive toxicity Must be removed to extremely low limits in GMP drugs DCM (dichloromethane / methylene chloride) Probable human carcinogen Central nervous system depressant Dangerous even in small amounts if injected TFA (trifluoroacetic acid) Corrosive Can remain in peptides as unmeasured TFA salt Pharmaceutical products often convert TFA salts to safer counterions Without validated HPLC, mass spectrometry, and residual solvent testing, patients may be injected with harmful chemical contaminants
Months 5-6: Stabilization and Long-Term Planning The final phase of six-month protocols focuses on stabilizing benefits and planning for long-term maintenance
